Steve Smith, M.B.A.
President
Pharmaceutical Product Development

Steve Smith is responsible for the product development unit of Constella Group. With staff in the United States and Europe, this unit provides pharmaceutical, biotechnology, and device companies with all the services required to take a new pharmaceutical product from concept to market. Smith is responsible for driving the unit's direction and growth, its revenue and earnings, and ensuring successful service delivery to its customers.

Smith has more than 20 years experience in the pharmaceutical industry with both large pharmaceutical companies and with contract research organizations (CROs). He joined Constella in March 2006 following the acquisition of Origin, the international CRO he founded with two partners in October 1999.

Smith started his career with Eli Lilly in agrochemical research and regulatory affairs before moving into clinical research as a clinical research associate (CRA). He then moved to Sandoz UK as a CRA and progressed, eventually running the dermatology and immunology therapeutic group. He then moved to Sandoz’s headquarters in Basle as group medical officer for immunology and dermatology, running its worldwide Phase IIIb/IV programs. In September 1995, Smith moved into corporate marketing at Sandoz as international product manager for transplantation. Following the merger of Sandoz and Ciba Geigy to form Novartis, Smith moved back to the UK to take a position as Director of Clinical Operations for Pharmakopius, a CRO. In October 1999, left to set up his own CRO with two colleagues, where he built Origin into a company with more than 100 people in UK , France, Germany, and the United States.